Thyrocare Technologies Limited
Thyrocare Technologies is engaged in the business of healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
What Thyrocare files
- Others82
- Investor Meet26
- Important23
- Updates18
- Insider Trade13
- Board Meeting10
Thyrocare delivered a robust Q1 FY27! Consolidated revenue surged 24% YoY to 240 Cr. Profit After Tax (PAT) jumped 34% YoY to 51.33 Cr, with EBITDA also up 34% YoY. Pathology, the core business, saw 26% growth, processing 55.2 Million tests (+28%) for 5.4 Million patients (+17%). Radiology revenue declined...
Thyrocare delivered a solid Q4FY26 with consolidated revenue up 20% YoY to ₹224 Cr and PAT soaring 128% YoY to ₹48.7 Cr. For the full FY26, revenue grew 21% YoY to ₹829 Cr, and PAT jumped 81% YoY to ₹162.85 Cr. EBITDA for FY26 was up 38% YoY to ₹262...
Thyrocare delivered a strong Q3 FY26 performance. Consolidated revenue surged 18% YoY to ₹195.5 Cr, with PAT jumping 47% YoY to ₹27.9 Cr. Normalized EBITDA grew 26% YoY to ₹62.2 Cr, marking a 32% margin. Pathology revenue, up 20% YoY, was primarily driven by robust 39% YoY growth in partnership...
Thyrocare delivered a strong quarter. **Business Performance:** Consolidated revenue grew 22% YoY to ₹216.53 Cr, fueled by pathology revenue rising 24%. Franchisee revenue climbed 20% to ₹125 Cr, and partnership revenue jumped 35% to ₹66 Cr. The company processed 5.33 crore tests, a 21% YoY increase, serving 5 million patients....
**1. Financial Highlights:** Consolidated revenue grew 23% YoY to 193 Cr, primarily from 25% pathology growth. Normalized EBITDA increased 42% YoY to 63.35 Cr (33% margin). Profit after tax jumped 62% YoY to 38.06 Cr. Key operational metrics, including active franchisees, patients, and tests, also showed strong double-digit growth. **2....